Given the role of Pak1/2 in the cardiovascular system, strategies targeting Pak1 and Pak2 could be promising avenues for treating cardiovascular disease by maintaining cellular homeostasis, metabolic function, and enhancing cardiomyocyte adaptation and resilience to stress. The gene discussed is PAK2; the disease is cardiovascular disorder.